Low Use of Standard-of-Care Antiparasitic Drugs and Increased Estimated Outpatient Payments for Treating Schistosomiasis in the United States, 2013–19

Drug utilization and payment estimates for standard-of-care treatment of schistosomiasis have not been reported previously in the United States. This study estimates the utilization of praziquantel (standard-of-care drug) among patients with schistosomiasis and outpatient payments among those who we...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Heesoo, Maskery, Brian A., Alpern, Jonathan D., Chancey, Rebecca J., Weinberg, Michelle, Stauffer, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651520/
https://www.ncbi.nlm.nih.gov/pubmed/35995136
http://dx.doi.org/10.4269/ajtmh.22-0254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651520/
https://www.ncbi.nlm.nih.gov/pubmed/35995136
http://dx.doi.org/10.4269/ajtmh.22-0254

Ejemplares similares